The understanding of the function of ␣ 1 -adrenergic receptors in the brain has been limited due to a lack of specific ligands and antibodies. We circumvented this problem by using transgenic mice engineered to overexpress either wild-type receptor tagged with enhanced green fluorescent protein or constitutively active mutant ␣ 1 -adrenergic receptor subtypes in tissues in which they are normally expressed. We identified intriguing ␣ 1A -adrenergic receptor subtype-expressing cells with a migratory morphology in the adult subventricular zone that coexpressed markers of neural stem cell and/or progenitors. Incorporation of 5-bromo-2-deoxyuridine in vivo increased in neurogenic areas in adult ␣ 1A -adrenergic receptor transgenic mice or normal mice given the ␣ 1A -adrenergic receptor-selective agonist, cirazoline. Neonatal neurospheres isolated from normal mice expressed a mixture of ␣ 1 -adrenergic receptor subtypes, and stimulation of these receptors resulted in increased expression of the ␣ 1B -adrenergic receptor subtype, proneural basic helix-loop-helix transcription factors, and the differentiation and migration of neuronal progenitors for catecholaminergic neurons and interneurons. ␣ 1 -Adrenergic receptor stimulation increased the apoptosis of astrocytes and regulated survival of neonatal neurons through phosphatidylinositol 3-kinase signaling. However, in adult normal neurospheres, ␣ 1 -adrenergic receptor stimulation increased the expression of glial markers at the expense of neuronal differentiation. In vivo, S100-positive glial and III tubulin neuronal progenitors colocalized with either ␣ 1 -adrenergic receptor subtype in the olfactory bulb. Our results indicate that ␣ 1 -adrenergic receptors can regulate both neurogenesis and gliogenesis that may be developmentally dependent. Our findings may lead to new therapies to treat neurodegenerative diseases.